{"id":"https://openalex.org/A5118963035","orcid":null,"observed_orcids":[],"display_name":"Kseniia E Ilina","raw_author_names":["Kseniia E Ilina","Kseniia E. Ilina","\u0418\u043b\u044c\u0438\u043d\u0430, \u041a\u0441\u0435\u043d\u0438\u044f \u042d\u0434\u0443\u0430\u0440\u0434\u043e\u0432\u043d\u0430"],"full_name":"Kseniia E. Ilina","works_count":3,"cited_by_count":4,"summary_stats":{"2yr_mean_citedness":1.3333333333333333,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5118963035","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I212220629","ror":"https://ror.org/02x91aj62","display_name":"Peter the Great St. Petersburg Polytechnic University","country_code":"RU","type":"education","lineage":["https://openalex.org/I212220629"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I212220629","ror":"https://ror.org/02x91aj62","display_name":"Peter the Great St. Petersburg Polytechnic University","country_code":"RU","type":"education","lineage":["https://openalex.org/I212220629"]}],"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":3,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","count":2,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","count":2,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","count":1,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","value":8.8e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","value":7.5e-06,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","value":7.1e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","value":6.2e-06,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","value":5.4e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","score":0.9185396432876587},{"id":"15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","score":0.8148000240325928},{"id":"115537861","wikidata":"https://www.wikidata.org/wiki/Q7645993","display_name":"Surface modification","score":0.43727290630340576},{"id":"171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","score":0.35420000553131104},{"id":"155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","score":0.32600000500679016}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":2},{"year":2026,"works_count":2,"oa_works_count":1,"cited_by_count":2}],"display_name_alternatives":["Kseniia E Ilina","Kseniia E. Ilina","\u0418\u043b\u044c\u0438\u043d\u0430, \u041a\u0441\u0435\u043d\u0438\u044f \u042d\u0434\u0443\u0430\u0440\u0434\u043e\u0432\u043d\u0430"],"block_key":"k ilina","works_api_url":"https://api.openalex.org/works?filter=author.id:A5118963035","awards_count":0,"updated_date":"2026-10-27T12:30:23","created_date":"2025-10-10T00:00:00"}